Singapore markets close in 5 minutes

Lexeo Therapeutics, Inc. (LXEO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
15.00-0.46 (-2.98%)
At close: 04:00PM EDT
15.00 0.00 (0.00%)
After hours: 04:11PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
654
1,657
518.476
Operating expenses
Research development
52,434
53,130
49,162
45,121
4,319
Selling general and administrative
20,080
15,383
12,001
7,173
787.499
Total operating expenses
72,514
68,513
61,163
52,294
5,106
Operating income or loss
-72,514
-68,513
-60,509
-50,637
-4,588
Interest expense
192
205
91
0
147.15
Total other income/expenses net
-544
-543
-2
-0.155
-417.85
Income before tax
-69,419
-66,394
-59,277
-50,622
-5,153
Income tax expense
0
0
0
0
0
Income from continuing operations
-69,419
-66,394
-59,277
-50,622
-5,153
Net income
-69,419
-66,394
-59,277
-50,622
-5,153
Net income available to common shareholders
-69,419
-66,394
-59,277
-50,622
-5,153
Basic EPS
-2.65
-12.40
-2.36
-2.01
-0.20
Diluted EPS
-2.65
-12.40
-2.36
-2.01
-0.20
Basic average shares
25,169
5,354
25,169
25,169
25,169
Diluted average shares
25,169
5,354
25,169
25,169
25,169